Table 4 Adjusted hazard ratio and 95% CI for risk of MACE at 6-, 12-, and 24-months post index date, stratified by COVID-19 hospitalization status. COVID-19 negative cohort was used as the reference. Hazard ratios were adjusted for all demographics, comorbidities and eGFR baseline.
6 months | P Value | 12 months | P Value | 24 months | P Value | |
|---|---|---|---|---|---|---|
Hospitalized COVID-19 | 1.73 [1.21,2.50] | < 0.001 | 1.77 [1.34,2.33] | < 0.001 | 1.31 [1.05,1.64] | 0.02 |
Non-hospitalized COVID-19 | 1.74 [1.07,2.83] | 0.02 | 1.72 [1.17,2.53] | 0.01 | 1.03 [0.73,1.44] | 0.89 |
